Last reviewed · How we verify
NCT07476755: MEDUSA-P
Cross-cultural Adaptation and Validation of the French Version of the Social Media Disorder Scale for Parents in a Sample of Parents of Children Aged 10 to 17
trial in Problematic Social Media Use in 300 participants. Completed in 31 January 2026.
31 January 2026
Quick facts
| Lead sponsor | Versailles Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 31 January 2025 |
| Primary completion | 31 January 2026 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across France |
Conditions studied
- Problematic Social Media Use — all drugs for Problematic Social Media Use →
Sponsor
Versailles Hospital
Who can join
Adults 10 to 17, any sex, with Problematic Social Media Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During the first lockdown related to the COVID-19 crisis, more than 12 million students in France were affected by school closures. Previous studies have shown that when children and adolescents are not in school, they are less physically active, spend more time in front of screens, and have disrupted sleep patterns. Parents are often the first to notice problems with their children's misuse of social media, and children tend to underestimate how often and how long they use social media. Therefore, given the increase in social media use and the limitations of self-assessment scales, it seems necessary to supplement the identification of problematic social media use in children with parental hetero-assessments. The main objective of the research is to translate, culturally adapt into French, and validate the parent version of the Social Media Disorder Scale (SMDS-P). The secondary objectives are 1) to determine the degree and meaning of discrepancies in the scores for problematic social media use obtained by the parent-child pair, and 2) to study the socio-demographic, clinical, and environmental factors associated with problematic social media use (according to the SMDS score) among preteens and teens. The population of interest consists of parent/children pairs aged 10 to 17. This population is recruited from consultants in the pediatrics and child psychiatry departments of the Centre Hospitalier de Versailles. This is a cross-sectional observational epidemiological study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07476755
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Versailles Hospital trials
Trials by the same sponsor.
- NCT07369245 — Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction · NA · not yet recruiting
- NCT07383779 — Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus · Phase 3 · not yet recruiting
- NCT06835491 — Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac · Phase 3 · recruiting
- NCT06650813 — Adapting the FACETS Program to Sickle Cell Disease · NA · recruiting
- NCT07350811 — Retrospective, Observationnal Study to Investigate Procedural Analgesia Delivered to Patients With Lacerations, Abrasion · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07476755 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Versailles Hospital
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07476755.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing